Healthcare Today Michigan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on February 26, 2026

41 minutes ago

Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics

GlobeNewswire

41 minutes ago

The Joint Corp. to Report 2025 Fourth Quarter and Full Year Results on Thursday, March 12 and Host Conference Call and Webcast

GlobeNewswire

41 minutes ago

Anika Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

41 minutes ago

Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights

GlobeNewswire

an hour ago

Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership

GlobeNewswire

an hour ago

Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results

GlobeNewswire

an hour ago

Amphista Therapeutics presents new data demonstrating how its advanced Eclipsys® platform is delivering Targeted Glue™ degraders using novel E3 ligases into the clinic

GlobeNewswire

an hour ago

Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call on March 5, 2026

GlobeNewswire

an hour ago

Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

an hour ago

C4 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

GlobeNewswire

an hour ago

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance

GlobeNewswire

an hour ago

Ligand Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

an hour ago

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update

GlobeNewswire

an hour ago

Akebia Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial and Pipeline Highlights

GlobeNewswire

an hour ago

Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance

GlobeNewswire

an hour ago

Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026

GlobeNewswire

an hour ago

BioCryst Reports Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire

an hour ago

TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03

GlobeNewswire

an hour ago

TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance

GlobeNewswire

an hour ago

AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder

GlobeNewswire